Posted by Michael Wonder on 10 Dec 2020
Pfizer plans to file for full FDA approval of COVID-19 vaccine in April 2021
11 December 2020 - Pfizer said on Thursday it planned to file for full U.S. approval of its experimental coronavirus vaccine by April next year, even as the vaccine awaits emergency use authorisation by the U.S. Food and Drug Administration.
The remarks were made by Pfizer executive William Gruber at a meeting of independent U.S. FDA advisers that are weighing emergency authorisation of the vaccine made by Pfizer and German partner BioNTech.
